Recent progress with microtubule stabilizers: New compounds, binding modes and cellular activities

Cristina C. Rohena, Susan L. Mooberry

Research output: Contribution to journalReview article

75 Scopus citations

Abstract

Covering: late 2008 to August 2013 Nature has yielded numerous classes of chemically distinct microtubule stabilizers. Several of these, including paclitaxel (Taxol) and docetaxel (Taxotere), are important drugs used in the treatment of cancer. New microtubule stabilizers and novel formulations of these agents continue to provide advances in cancer therapy. In this review we cover recent progress in the chemistry and biology of these diverse microtubule stabilizers focusing on the wide range of organisms that produce these compounds, their mechanisms of inhibiting microtubule-dependent processes, mechanisms of drug resistance, and their interactions with tubulin including their distinct binding sites and modes. A new potential role for microtubule stabilizers in neurodegenerative diseases is reviewed.

Original languageEnglish (US)
Pages (from-to)335-355
Number of pages21
JournalNatural Product Reports
Volume31
Issue number3
DOIs
StatePublished - Mar 1 2014

ASJC Scopus subject areas

  • Biochemistry
  • Drug Discovery
  • Organic Chemistry

Fingerprint Dive into the research topics of 'Recent progress with microtubule stabilizers: New compounds, binding modes and cellular activities'. Together they form a unique fingerprint.

Cite this